Hard to know, could be any day. Originally they expected to be done with the pre clinicals at the end of the first quarter but in the course of the testing they discovered a new method which the CEO stated was "vastly superior" to the original. They just applied for a new non provisional patent. My guess would be that this will lengthen the time of trials but maybe not if they had enough to file for a new patent. The only thing we have been told is that the initial results will be released 2nd quarter. Considering they want to uplist by the middle of summer I would expect a strong campaign to begin very shortly.
News 
Market Data 
Discover 
